Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and ...

The approval of Hympavzi Friday was a dose of good news for Pfizer, which is dealing with research setbacks and a challenge ...

The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen ...

Pfizer PFE announced that the FDA has approved its subcutaneously administered drug marstacimab for treating certain ...

The FDA has approved a new preventive treatment for people with certain types of hemophilia that can reduce bleeding episodes, sometimes down to just a few per year.

H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

Results from a new study suggest a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could ...

Burke is one of a growing number of adults who suspect they might have undiagnosed ADHD. About 25% of adults think they have ...

Drugmakers and insurers are exploring different payment schemes for expensive, potentially curative treatments, particularly ones tied to patient response.

Danish CNS specialist Lundbeck today revealed that it has reached to acquire Longboard Pharmaceuticals. Lundbeck said it will ...

One doctor spoke out warning that women may be getting misdiagnosed with a common condition when they may actually be ...

Cancer Research UK hailed the shift as the biggest improvement in cervical cancer treatment in more than 20 years ...